Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 29Ovarian Neoplasms 23Carcinoma, Ovarian Epithelial 18Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Neuroblastoma 13Central Nervous System Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Brain Neoplasms 8Brenner Tumor 7Adenocarcinoma, Bronchiolo-Alveolar 7Urinary Bladder Neoplasms 6Urethral Neoplasms 5Breast Neoplasms 5Astrocytoma 5Wilms Tumor 4Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Teratoma 3Radiation Injuries 3Optic Nerve Glioma 3Lymphoma 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Embryonal 3Carcinoma 3Thymoma 2

Interventions

Paclitaxel 2etoposide phosphate 1Taxes 1Platinum 1Cisplatin 1Carboplatin 1Bleomycin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sertoli-Leydig Cell Tumor × Carboplatin × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡